Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan

• Tatsuya Yamashita ,

  Roles Writing – review & editing

  * E-mail: ytatsuya28@gmail.com

  Affiliation Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan

  https://orcid.org/0000-0002-3602-8086

  ⨯
• Natsumi Suzuki,

  Roles Conceptualization, Formal analysis, Writing – review & editing

  Affiliation Eisai Co., Ltd., Tokyo, Japan

  ⨯
• Katsuaki Motoyoshi,

  Roles Conceptualization, Supervision, Writing – original draft

  Affiliation Eisai Co., Ltd., Tokyo, Japan

  ⨯
• Wanjun Zhu,

  Roles Conceptualization, Formal analysis, Writing – review & editing

  Affiliation Eisai Co., Ltd., Tokyo, Japan

  ⨯
• Junji Furuse

  Roles Writing – review & editing

  Affiliation Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan

  ⨯